Cargando…

How Safe are Fluoroquinolones for Diabetic Patients? A Systematic Review of Dysglycemic and Neuropathic Effects of Fluoroquinolones

INTRODUCTION: The US Food and Drug Administration issued safety warnings about neuropathy in 2013 and dysglycemia in 2018 caused by fluoroquinolone use, mainly based on case reports and case series. We conducted this systematic review to evaluate the safety of fluoroquinolones in diabetic patients b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Althaqafi, Abdulrhman, Ali, Majid, Alzahrani, Yusuf, Ming, Long Chiau, Hussain, Zahid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520959/ https://www.ncbi.nlm.nih.gov/pubmed/34675522 http://dx.doi.org/10.2147/TCRM.S284171

Ejemplares similares

Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan
por: Abbas, Muhammad, et al.
Publicado: (2023)

Etymologia: Fluoroquinolone
por: Henry, Ronne
Publicado: (2017)

Resistance patterns, prevalence, and predictors of fluoroquinolones resistance in multidrug resistant tuberculosis patients
por: Ahmad, Nafees, et al.
Publicado: (2015)

High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli
por: Rattanaumpawan, Pinyo, et al.
Publicado: (2017)

Corneal plates of fluoroquinolone
por: El Mellaoui, Mohammed, et al.
Publicado: (2014)

Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use
por: Lamikanra, Adebayo, et al.
Publicado: (2011)

Hypersensitivity to fluoroquinolones: The expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone
por: Fernández, Tahia D., et al.
Publicado: (2016)

Factors Influencing Fluoroquinolone Resistance
por: Sahm, Daniel F., et al.
Publicado: (2003)

Fluoroquinolone resistance in Neisseria gonorrhoeae.
por: Knapp, J S, et al.
Publicado: (1997)

Fluoroquinolone Use in Food Animals
por: Collignon, Peter
Publicado: (2005)

Fluoroquinolone-resistant Streptococcus pneumoniae
por: Pletz, Mathias W.R., et al.
Publicado: (2006)

Emerging mechanisms of fluoroquinolone resistance.
por: Hooper, D C
Publicado: (2001)

Systemic use of fluoroquinolone in children
por: Choi, Soo-Han, et al.
Publicado: (2013)

Reproductive toxicity of fluoroquinolones in birds
por: Hruba, Hana, et al.
Publicado: (2019)

Trends in fluoroquinolone resistance in Campylobacter
por: Sproston, Emma L., et al.
Publicado: (2018)

Herbicidal activity of fluoroquinolone derivatives
por: Wallace, Michael D., et al.
Publicado: (2021)

Fluoroquinolone antibiotics and adverse events
por: Baggio, Diva, et al.
Publicado: (2021)

Analysis of fluoroquinolones in dusts from intensive livestock farming and the co-occurrence of fluoroquinolone-resistant Escherichia coli
por: Schulz, Jochen, et al.
Publicado: (2019)

Emergence of Fluoroquinolone-Resistant Campylobacter jejuni and Campylobacter coli among Australian Chickens in the Absence of Fluoroquinolone Use
por: Abraham, Sam, et al.
Publicado: (2020)

Role of fluoroquinolone prophylaxis in allogeneic hematopoietic cell transplantation in regions with a high prevalence of fluoroquinolone resistance
por: Nair, Ashwin, et al.
Publicado: (2023)

Fluoroquinolone-Resistant Typhoid, South Africa
por: Keddy, Karen H., et al.
Publicado: (2010)

Fluoroquinolone-resistant Escherichia coli, Indonesia
por: Kuntaman, Kuntaman, et al.
Publicado: (2005)

Fluoroquinolone Resistance and Clostridium difficile, Germany
por: Zaiß, Nils Henning, et al.
Publicado: (2010)

Fluoroquinolone-resistant Salmonella Paratyphi A
por: Adachi, Takuya, et al.
Publicado: (2005)

Fluoroquinolone-resistant Salmonella sp. in Carcasses
por: Wang, Yu-Chih, et al.
Publicado: (2006)

Fluoroquinolones: An under-recognized cause for delirium
por: Chowdhry, Vivek, et al.
Publicado: (2015)

Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells
por: Badal, Sujan, et al.
Publicado: (2015)

The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019
por: Pranger, A. D., et al.
Publicado: (2019)

Evaluation of disability in patients exposed to fluoroquinolones
por: Wilcox, Marsha A., et al.
Publicado: (2020)

Fluoroquinolones and Aortic Diseases: Is There a Connection
por: Carino, Davide, et al.
Publicado: (2019)

1787. County Level Association Between the Rate of Fluoroquinolone-Resistance Gram Negative Bacteria and Fluoroquinolone Utilization in Kansas
por: Fulmer, Robert D, et al.
Publicado: (2022)

Fluoroquinolone Analogs, SAR Analysis, and the Antimicrobial Evaluation of 7-Benzimidazol-1-yl-fluoroquinolone in In Vitro, In Silico, and In Vivo Models
por: Medellín-Luna, Mitzzy Fátima, et al.
Publicado: (2023)

Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
por: Shen, Gwan-Han, et al.
Publicado: (2012)

Fluoroquinolone-associated tendinopathy: a case report
por: Ng, Wan-Fai, et al.
Publicado: (2007)

The Persistence of Fluoroquinolone-Resistant Campylobacter in Poultry Production
por: Price, Lance B., et al.
Publicado: (2007)

Unnecessary use of fluoroquinolone antibiotics in hospitalized patients
por: Werner, Nicole L, et al.
Publicado: (2011)

Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness
por: Marcusson, Linda L., et al.
Publicado: (2009)

Pseudomonas aeruginosa, Staphylococcus aureus, and Fluoroquinolone Use
por: MacDougall, Conan, et al.
Publicado: (2005)

Relative Fitness of Fluoroquinolone-resistant Streptococcus pneumoniae
por: Johnson, Crystal N., et al.
Publicado: (2005)

Newer fluoroquinolones in the treatment of acute exacerbations of COPD
por: Patel, Amit, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_jgpprigfvuavairor02u6iki01